Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 5,521 | 3,973 | 3,128 | 3,364 | 3,536 |
| Operating Income | -5,521 | -3,973 | -3,128 | -3,364 | -3,536 |
| Other Income | 256 | 229 | 76 | 13 | 35 |
| Pre-tax Income | -5,265 | -3,744 | -3,052 | -3,351 | -3,501 |
| Income Tax | 7 | 7 | 7 | 7 | 7 |
| Net Income Continuous | -5,272 | -3,751 | -3,059 | -3,358 | -3,508 |
| Net Income | $-5,272 | $-3,751 | $-3,059 | $-3,358 | $-3,508 |
| EPS Basic Total Ops | -0.20 | -0.14 | -0.12 | -0.13 | -0.13 |
| EPS Basic Continuous Ops | -0.20 | -0.14 | -0.12 | -0.13 | -0.13 |
| EPS Diluted Total Ops | -0.20 | -0.14 | -0.12 | -0.13 | -0.13 |
| EPS Diluted Continuous Ops | -0.20 | -0.14 | -0.12 | -0.13 | -0.13 |
| EBITDA(a) | $-5,719 | $-4,096 | $-3,163 | $-3,318 | $-3,410 |